Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 153.02 USD -0.26% Market Closed
Market Cap: 17.1B USD
Have any thoughts about
Quest Diagnostics Inc?
Write Note

Quest Diagnostics Inc
Investor Relations

In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions.

Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Sam A. Samad
Executive VP & CFO
No Bio Available
Mr. Michael E. Prevoznik J.D.
Senior VP & General Counsel
No Bio Available
Mr. Karthik Kuppusamy Ph.D.
Senior Vice President of Clinical Solutions
No Bio Available
Mr. Michael J. Deppe
Senior VP, Corporate Controller & Chief Accounting Officer
No Bio Available
Mr. Murali Balakumar
Senior VP, Chief Information & Digital Officer
No Bio Available
Ms. Kristin Lee Wallace Esq.
Senior VP & Chief Compliance Officer
No Bio Available
Mr. Gary D. Samuels
Senior VP & Chief Communications Officer
No Bio Available
Ms. Cecilia K. McKenney
Senior VP & Chief Human Resources Officer
No Bio Available
Mr. Dermot V. Shorten
Senior Vice President of Strategy, M&A and Ventures
No Bio Available
Mr. Patrick T. Plewman
Senior Vice President of Diagnostic Services
No Bio Available

Contacts

Address
NEW JERSEY
Secaucus
500 Plaza Dr
Contacts